Lessons med device industry can learn from pharma

February 2016

Shaden Marzouk , MD MBA
Vice President, Clinical Affairs


The U.S. healthcare system is undergoing fundamental change. Consumers are increasingly focused on lower costs and more convenient access to care. Healthcare delivery stakeholders have to work toward expense reductions without compromising quality. All of this is occurring within an atmosphere of declining reimbursements, pay-for-performance metrics, and a shift from acute sites of care to outpatient centers and the home. Employers are also driving expenditure-conscious practices. Despite this milieu, CMS is projecting health spending to grow at an average rate of 5.8% from 2012-2022 – 1% faster than expected average annual GDP growth – to be 19.9% of GDP by 2022.1


1 National Health Expenditure Projections 2012-2022; http://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/downloads/proj2012.pdf

Enter your email address to receive the Connect newsletter.

*
By submitting this form, you consent to receive relevant email communications from Cardinal Health. We will not sell or share your personal information and you may unsubscribe at any time.